Synairgen (LON:SNG) Shares Pass Below 200 Day Moving Average – Should You Sell?

Shares of Synairgen plc (LON:SNG) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 4.94 ($0.06) and traded as low as GBX 4.60 ($0.06). Synairgen shares last traded at GBX 4.77 ($0.06), with a volume of 129,781 shares traded.

Synairgen Trading Up 5.9 %

The company’s fifty day moving average is GBX 4.03 and its two-hundred day moving average is GBX 4.94. The company has a quick ratio of 6.35, a current ratio of 6.77 and a debt-to-equity ratio of 0.09. The stock has a market cap of £9.60 million, a price-to-earnings ratio of -158.83 and a beta of -2.23.

Synairgen Company Profile

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.